Affinity Technology Raises $1.9 Million in Additional Funding.

COLUMBIA, S.C. -- Affinity Technology Group, Inc. (OTCBB: AFFI) today announced that it has raised $1.9 million through the sale of additional convertible notes under its convertible note program. The convertible notes mature in two years, are convertible into the Company's common stock at $.42 per share, and are secured by all the outstanding stock of the Company's wholly-owned patent licensing subsidiary, decisioning.com, Inc. The notes were issued in a private placement transaction. However, Affinity has agreed to prepare and file with the Securities and Exchange Commission, on or before January 31, 2007, a registration statement with respect to Affinity's common stock issuable upon conversion of the notes.

Mr. Boyle stated, "We were very pleased with the interest in this round of the Company's financing activities. This is the first sale of our convertible notes since the program was restructured and expanded to $5 million last month. This is by far our largest and most significant placement since we started the convertible note program four years ago. We plan to use the proceeds to support the further commercialization of our intellectual property."

About Affinity Technology Group, Inc.

Through its subsidiary, decisioning.com, Inc., Affinity Technology Group, Inc. owns a portfolio of patents that covers the automated processing and establishment of loans, financial accounts and credit accounts through an applicant-directed remote interface, such as a personal computer or terminal touch screen. Affinity's patent portfolio includes U. S. Patent No. 5,870,721C1, No. 5,940,811C1, and No. 6,105,007C1.

Forward-looking statements in this news release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We cannot offer any assurances that Affinity will prevail on its claims of patent infringement against third parties or that such claims will result in monetary damages to Affinity. Investors are cautioned that our business is subject to several additional risks and uncertainties, including the risk that we may lose all or part of the claims covered by our patents as a result of challenges to our patents; the risk that our patents may be subject to additional reexamination by the U.S. Patent and Trademark Office or challenge by third parties; the result of ongoing litigation, including our patent litigation; and unanticipated costs and expenses affecting the Company's cash position. These and other factors may cause actual results to differ materially from those anticipated.